ZMYND8 is a master regulator of 27-hydroxycholesterol that promotes tumorigenicity of breast cancer stem cells

Author:

Luo Maowu1ORCID,Bao Lei1ORCID,Chen Yan1ORCID,Xue Yuanyuan2ORCID,Wang Yong1,Zhang Bo1,Wang Chenliang1ORCID,Corley Chase D.3ORCID,McDonald Jeffrey G.34ORCID,Kumar Ashwani5,Xing Chao567ORCID,Fang Yisheng1ORCID,Nelson Erik R.8910ORCID,Wang Jennifer E.1ORCID,Wang Yingfei11112ORCID,Luo Weibo113ORCID

Affiliation:

1. Department of Pathology, UT Southwestern Medical Center, Dallas, TX, USA.

2. Children’s Medical Center Research Institute, UT Southwestern Medical Center, Dallas, TX, USA.

3. Center for Human Nutrition, UT Southwestern Medical Center, Dallas, TX, USA.

4. Department of Molecular Genetics, UT Southwestern Medical Center, Dallas, TX, USA.

5. Eugene McDermott Center for Human Growth and Development, UT Southwestern Medical Center, Dallas, TX, USA.

6. Lyda Hill Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.

7. Department of Population and Data Sciences, UT Southwestern Medical Center, Dallas, TX, USA.

8. Department of Molecular and Integrative Physiology, University of Illinois Urbana-Champaign, Urbana, IL, USA.

9. Cancer Center at Illinois, University of Illinois Urbana-Champaign, Urbana, IL, USA.

10. Carl R. Woese Institute for Genomic Biology, University of Illinois Urbana-Champaign, Urbana, IL, USA.

11. Department of Neurology, UT Southwestern Medical Center, Dallas, TX, USA.

12. Peter O’Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas, TX, USA.

13. Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA.

Abstract

27-Hydroxycholesterol (27-HC) is the most abundant oxysterol that increases the risk of breast cancer progression. However, little is known about epigenetic regulation of 27-HC metabolism and its role in breast tumor initiation. Using genetic mouse mammary tumor and human breast cancer models, we showed here that the histone reader ZMYND8 was selectively expressed in breast cancer stem cells (BCSCs) and promoted epithelial-mesenchymal transition (EMT), BCSC maintenance and self-renewal, and oncogenic transformation through its epigenetic functions, leading to breast tumor initiation. Mechanistically, ZMYND8 was a master transcriptional regulator of 27-HC metabolism. It increased cholesterol biosynthesis and oxidation but blocked cholesterol efflux and 27-HC catabolism, leading to accumulation of 27-HC in BCSCs. Consequently, 27-HC promoted EMT, oncogenic transformation, and tumor initiation through activation of liver X receptor. These findings reveal that ZMYND8 is an epigenetic booster that drives breast tumor initiation through metabolic reprogramming.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3